The Future of
Life-saving Treatments

Vision & Mission

We create the future of life-saving treatments by aiming to reduce the organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology.

About us
Business areas
LUMEN X™ - The New Standard for Light Bioprinting
High Resolution Confocal Imaging Made Easy
Introducing the Echo Confocal microscope

Say goodbye to

Animal Testing Manual Work Static Analysis

Explore The Lab of The Future

Automated Laboratory Workflows Through Bioconvergence

Learn how synergies between our technologies enable laboratories to develop new drugs faster and more cost efficient.

Learn more
What is bioconvergence?

Bico by numbers

  • Net sales July-September 2023
    0 MSEK
  • Organic growth July-September 2023
    0 %
  • Employees
    0 +
  • Instruments in the field
    0 +
  • Publications
    0 +
  • Countries
    0 +
Investor relations
Investor Relations

Products that Fuel Groundbreaking Scientific Discoveries

Learn more

Trusted By Your Favorite Treatment Provider
View customer stories
Foto: Felix Groteloh
CYTENA_116_By_Felix_Groteloh
06 kopiera
_MG_1296 kopiera
DSC_7861 kopiera
20 kopiera
lab_16 (1) kopiera
IMG_7983 (1)
covid-19-bico
bico-people
bico-biosciences-hero

BICO News Feed​

November 30, 2023
Cellink CELLINK and Ossiform Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform’s P3D Bone material
November 21, 2023
Cellenion Cellenion Launches proteoCHIP EVO 96 – Tailored for robust and high-throughput liquid chromatography
November 16, 2023
Scienion MEDICA 2023: reliable, versatile, and trusted solutions for innovative diagnostics
October 18, 2023
Cellink CELLINK Announces CELLINK Vivoink: Our First Medical-Grade Bioink 
Learn more

press releases

11/14/23RegulatoryPublication of BICO Group interim report July – September 2023
11/13/23Maria Forss assumes office as BICO’s CEO and President on November 20, 2023
11/13/23BICO has divested Ginolis
11/09/23RegulatoryBICO Group AB Nomination Committee 2024 AGM appointed
11/06/23Invitation to the presentation of BICO’s interim report Q3, 2023
11/01/23RegulatoryBICO releases preliminary revenue, EBITDA, and cash flow from operating activities for Q3, 2023
08/22/23Appointed CEO and President Maria Forss has acquired shares in BICO Group AB (publ)
08/22/23Invitation to webcast with CEO and Chairman of the Board: company update with regards to CEO-change, Q2 report and goodwill impairment
08/22/23RegulatoryPublication of BICO Group interim report April – June 2023
08/21/23RegulatoryBICO announces goodwill impairment predominantly due to increased WACC, and write-downs of assets
08/21/23RegulatoryMaria Forss is appointed new President and CEO of BICO Group AB (publ)
08/11/23Invitation to the presentation of BICO’s interim report Q2, 2023
08/03/23BICO divests Berlin property for a total of EUR 21m
07/27/23Initiating next phase in integration process with enhanced commercial strategy and customer-centric operating model to be established in H2, 2023
07/03/23Next step in Sartorius partnership finalized: several sub-sales and distribution agreements as well as R&D project agreements have been signed
05/09/23RegulatoryBulletin from Annual General Meeting in BICO Group AB (publ)
05/04/23RegulatoryPublication of BICO Group interim report January – March 2023
04/24/23Invitation to the presentation of BICO’s interim report Q1, 2023
04/04/23RegulatoryNotice to attend the Annual General Meeting in BICO Group AB (publ)
03/17/23RegulatoryBICO Publishes Annual Report and Sustainability Report 2022
02/27/23BICO introduces new life sciences manufacturing platform integrating ABB Robotics technology
02/24/23Discover Echo Launches New Confocal Microscope for High-Resolution Imaging
02/22/23RegulatoryPublication of year-end Report January – December 2022
02/21/23RegulatoryBICO announces goodwill impairment related to post-pandemic downturn in Ginolis
02/13/23Invitation to presentation of BICO’s Year-end results 2022
02/03/23Rolf Classon proposed as new Chairman of BICO Group AB (publ)
01/31/23RegulatoryBICO Group AB (publ) announces an increase in number of shares and votes
01/05/23RegulatoryBICO appoints COO
01/02/23RegulatoryBICO Group Appoints New CFO
12/30/22RegulatoryBICO Group AB (publ) announces an increase in number of shares and votes
12/14/22RegulatoryBulletin from Extraordinary General Meeting in BICO Group AB (publ)
12/08/22RegulatoryBICO agrees with Sartorius on strategic cooperation, followed by a SEK 487m directed share issue of shares to Sartorius
11/14/22RegulatoryNotice of extraordinary general meeting in BICO Group AB (publ)
11/10/22RegulatoryBICO Group announces new financial targets
11/09/22RegulatoryPublication of Interim Report January – September 2022
10/28/22RegulatoryBICO Group Nomination Committee 2023 AGM appointed
10/26/22Invitation to presentation of BICO’s Q3 results 2022
10/10/22Welcome to BICO Group’s Capital Markets Day 2022
08/24/22RegulatoryPublication of Interim Report January – June 2022
08/17/22Invitation to presentation of BICO’s Q2 results 2022
07/17/22Invitation to presentation of BICO’s preliminary Q2 performance 2022
07/15/22RegulatoryBICO announces preliminary financial performance for the second quarter
05/18/22RegulatoryBICO Publishes Interim Report January – March 2022: Continued growth in sales, improved profitability and focus on commercial synergies
05/12/22RegulatoryBICO Group adds senior IR manager to its executive management
05/11/22Invitation to presentation of BICO’s Q1 results 2022
05/06/22BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology – complementing the existing offering of application tailored products
05/02/22RegulatoryBusiness update for BICO Group AB (publ)
04/29/22New Interim CFO at BICO
Learn more

FINANCIAL REPORTS

Learn more

Calendar